http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I749460-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b1fcdbb3e195e74ed20d09c421d1039 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-095 |
| filingDate | 2020-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0590e3cca39539fa9826c534325ccae0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_972cfbbe0217488929c775e2039f09a6 |
| publicationDate | 2021-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-I749460-B |
| titleOfInvention | Isolated liver cancer stem cell and method for drug screening thereof |
| abstract | The invention is an isolated rat liver cancer stem cell line which is named TW-1, wherein the isolated rat liver cancer stem cell line has been deposited in Food Industry Research and Development Institute (Taiwan) with the depositing number BCRC960524. The invention also provides a method for drug screening by using the isolated rat liver cancer stem cell line. |
| priorityDate | 2020-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.